Corvus Pharmaceuticals (CRVS) IPO Opens Flat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St ends higher on cool inflation data, strong earnings
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices make small gain on smaller US inventory draw
- ASML capacity upgrade soothes AI chip bottleneck fears
Corvus Pharmaceuticals (CRVS) IPO Prices at $15, Low-End of Range
March 22, 2016 6:13 PM EDTCorvus Pharmaceuticals, Inc. (NASDAQ: CRVS) announced the pricing of its initial public offering of 4,700,000 shares of its common stock at an initial public offering price of $15 per share, the low end of the expected $15-$17 range. In addition, the underwriters have a 30-day... More
